Safety and Effectiveness of Regorafenib in Sorafenib Treated Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: An International Multicenter Study

被引：0

作者：

Iavarone, Massimo ^{[1
,2
,3
]}

Invernizzi, Federica ^{[1
,2
,3
]}

Czauderna, Carolin ^{[4
]}

Sanduzzi Zamparelli, Marco ^{[5
]}

Bhoori, Sherrie ^{[6
,7
]}

Amaddeo, Giuliana ^{[8
]}

Manini, Matteo ^{[9
]}

Fraile Lopez, Miguel ^{[10
]}

Anders, Margarita ^{[11
]}

Pinter, Matthias ^{[12
]}

Blanco Rodriguez, Maria Jose ^{[13
]}

Romero Cristobal, Mario ^{[14
]}

Aballay Soteras, Gabriel ^{[15
]}

Pinero, Federico ^{[16
]}

Villadsen, Gerda Elisabeth ^{[17
]}

Weinmann, Arndt ^{[18
]}

Crespo, Gonzalo ^{[19
]}

Mazzaferro, Vincenzo ^{[6
,7
]}

Regnault, Helene ^{[20
]}

De Giorgio, Massimo ^{[9
]}

Gonzalez Dieguez, Maria Luisa ^{[21
]}

Donato, Maria Francesca ^{[1
,2
,3
]}

Varela, Maria ^{[10
]}

Worns, Marcus ^{[4
]}

Lampertico, Pietro ^{[1
,2
,3
]}

Reig, Maria ^{[5
]}

机构：

[1] Univ Milan, CRC AM & A Migliavacca Ctr Liver Dis, Milan, Italy

[2] Univ Milan, Div Gastroenterol & Hepatol, Milan, Italy

[3] Fdn Irccs Ca Granda Maggiore Hosp, Milan, Italy

[4] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany

[5] Univ Barcelona, Hosp Clin, Barcelona Clin Liver Canc BCLC Grp, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain

[6] Univ Milan, Liver Surg Transplantat & Gastroenterol, Milan, Italy

[7] Ist Nazl Tumori Fdn Irccs, Milan, Italy

[8] Hop Henri Mondor, Serv Hepatol, Virus Immunite Canc, Equipe 18,Inserm,U955, Creteil, France

[9] Azienda Socio Sanit Terr ASST Papa Giovanni XXIII, Dept Specialty & Transplant Med, Gastroenterol Hepatol & Transplant Unit, Bergamo, Italy

[10] Hosp Univ Cent Asturias, Liver Unit, Oviedo, Spain

[11] Hosp Aleman, Unidad Hepatol & Trasplante Hepat, Buenos Aires, DF, Argentina

[12] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria

[13] Hosp Jerez, Jerez de la Frontera, Spain

[14] Gregorio Maranon Hosp, Liver Dept, Madrid, Spain

[15] Sanat Trinidad Mitre, Buenos Aires, DF, Argentina

[16] Hosp Univ Austral, Buenos Aires, DF, Argentina

[17] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus C, Denmark

[18] Johannes Gutenberg Univ Mainz, Dept Med 1, Mainz, Germany

[19] Univ Barcelona, Hosp Clin, Liver Transplant Unit, Liver Unit,Idibaps,Ciberehd, Barcelona, Spain

[20] Hop Henri Mondor, Serv Hepatol, Virus Immunite Canc, Equipe 18,Inserm,U955, Creteil, France

[21] Hosp Univ Cent Asturias, Liver Transplant Unit, Buenos Aires, DF, Argentina

来源：

HEPATOLOGY | 2018年 / 68卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB-17

引用

页码：1457A / 1458A

页数：2

共 50 条

[21] High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
Staufer, Katharina
Fischer, Lutz
Seegers, Barbara
Vettorazzi, Eik
Nashan, Bjoern
Sterneck, Martina
TRANSPLANT INTERNATIONAL, 2012, 25 (11) : 1158 - 1164
[22] Sorafenib for recurrent hepatocellular carcinoma after liver transplantation: Intrinsic resistance or not?
Tovoli, Francesco
Sansone, Vito
Di Costanzo, Giovan Giuseppe
Magini, Giulia
Sacco, Rodolfo
Pressiani, Tiziana
Trevisani, Franco
Tortora, Raffaella
Bucci, Laura
Luca, Maria Grazia
Bolondi, Luigi
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E619 - E620
[23] Use of sorafenib in recurrent hepatocellular carcinoma (HCC) after liver transplantation
Chiu, Joanne Wing-Yan
Yau, Thomas Cheung
Cheung, Tan To
Chan, Albert
Chok, Siu-Ho
Dai, Wing-Chiu
Leung, Roland Ching-Yu
Chan, See-Ching
Lo, Chung-Mau
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
[24] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
Feun, L. G.
Levi, D.
Moon, J.
Nishida, S.
Island, E.
Selvaggi, G.
Martin, P.
Savaraj, N.
Mendes, F.
Tzakis, A.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[25] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: safety and survival
Mazza, S.
Invernizzi, F.
Iavarone, M.
Zavaglia, C.
Maggi, U.
Cesarini, L.
Antonelli, B.
Airoldi, A.
Manini, M. A.
Sangiovanni, A.
Rossi, G.
Donato, M. F.
Belli, L. S.
Lampertico, P.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E35 - E35
[26] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
Invernizzi, F.
Iavarone, M.
Donato, M. F.
Sangiovanni, A.
Monico, S.
Manini, M. A.
Maggi, U.
Antonelli, B.
Dondossola, D.
Rossi, G.
Lampertico, P.
DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 49 - 49
[27] Early treatment with sorafenib and mTOR inhibitor in recurrent hepatocellular carcinoma after liver transplantation: Safety and survival
Invernizzi, Federica
Iavarone, Massimo
Zavaglia, Claudio
Mazza, Stefano
Maggi, Umberto
Cesarini, Lucia
Antonelli, Barbara
Airoldi, Aldo
Manini, Matteo Angelo
Sangiovanni, Angelo
Rossi, Giorgio
Donato, Maria Francesca
Belli, Luca Saverio
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E560 - E561
[28] Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
Bang, Kyunghye
Casadei-Gardini, Andrea
Yoo, Changhoon
Iavarone, Massimo
Ryu, Min-Hee
Park, Sook Ryun
Kim, Hyung-Don
Yoon, Young-In
Jung, Dong-Hwan
Park, Gil-Chun
Ahn, Chul-Soo
Moon, Deok-Bog
Hwang, Shin
Kim, Ki-Hun
Song, Gi-Won
Mazzarelli, Chiara
Alimenti, Eleonora
Chan, Stephen L.
De Giorgio, Massimo
Ryoo, Baek-Yeol
Lee, Sung-Gyu
CANCER MEDICINE, 2023, 12 (03): : 2572 - 2579
[29] Can Sorafenib Increase Survival for Recurrent Hepatocellular Carcinoma after Liver Transplantation? A Pilot Study
Alsina, Angel E.
Makris, Alexia
Nenos, Vasilios
Sucre, Eduardo
Arrobas, Jade
Franco, Edson
Kemmer, Nyingi
AMERICAN SURGEON, 2014, 80 (07) : 680 - 689
[30] Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation?
Cho, Eun Ju
Kang, Seong Hee
Cho, Hyeki
Cho, Young Youn
Lee, Jeong-Hoon
Yu, Su Jong
Kim, Yoon Jun
Yoon, Jung-Hwan
HEPATOLOGY, 2016, 64 : 658A - 658A

← 1 2 3 4 5 →